HAE : Analysis & Opinions

  1. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  2. Illumina, Teva Spread NIPT in Israel - Analyst Blog

    July 3, 2013
    Verinata Health, a division of Illumina Inc., entered into an exclusive agreement with Teva Pharmaceutical Industries Ltd.
  3. BSX to Take Over Bard EP Division - Analyst Blog

    July 1, 2013
    Boston Scientific Corporation announced its plans to acquire Bard EP, the electrophysiology business of C.R. Bard.
  4. Quest Diagnostics Partners AT&T - Analyst Blog

    June 27, 2013
    Quest Diagnostics formed an alliance with AT&T products and services, subsidiaries and affiliates of AT&T Inc.
  5. TMO Launches R&D Facility in China - Analyst Blog

    June 26, 2013
    Thermo Fisher recently launched its $9.5 million China Innovation Center in Shanghai.
  6. DGX Closes Dignity Health Acquisition - Analyst Blog

    June 25, 2013
    Quest Diagnostics recently completed the acquisition of lab-related clinical outreach service operations of Calif-based Dignity ...
  7. Edwards' Sapien XT Now in Japan - Analyst Blog

    June 25, 2013
    Edwards receives regulatory approval for Sapien XT in Japan.
  8. Walgreens 3Q Earnings: Will it Miss? - Analyst Blog

    June 21, 2013
    Walgreens is set to report third-quarter fiscal 2013 results on Jun 25.
  9. Positive Data for COV's Pipeline - Analyst Blog

    June 21, 2013
    Covidien published the final results of the Pipeline for Uncoilable or Failed Aneurysms clinical study, designed to analyze ...
  10. SNN's New Alliance for IV3000 Range - Analyst Blog

    June 20, 2013
    Smith & Nephew partners United Drug Medical to promote IV3000 line.
  11. LIFE Expands in China with Ribo - Analyst Blog

    June 20, 2013
    Recently Life Technologies came up with a new licensing agreement with Kunshan, China-based Suzhou Ribo Life Sciences Co. ...
  12. Positive Data for COV's Solitaire - Analyst Blog

    June 17, 2013
    Covidien presented encouraging data at the 2013 ESC regarding the superiority of its Solitaire FR device for acute ischemic ...
  13. LIFE Continues Korean Expansion - Analyst Blog

    June 14, 2013
    Life Technologies recently acquired a South Korea-based distributor, Life Science Korea.
  14. FDA Nod for STJ's Ellipse & Assura - Analyst Blog

    June 13, 2013
    St. Jude has won the U.S. FDA approval for its Ellipse and SJM Assura portfolio of ICDs and CRT-Ds.
  15. CardioNet Skyrockets on New Deal - Analyst Blog

    June 12, 2013
    Shares of CardioNet surge on the back of expanded coverage for its offerings.
  16. Symmetry Provides Dismal 2013 View - Analyst Blog

    June 11, 2013
    Symmetry has revised its guidance for 2013 based on the company's disappointing first-quarter results as well as a tempered ...
  17. Quest Scans 2Q; Maintains FY13 View - Analyst Blog

    June 10, 2013
    Quest Diagnostics reaffirms outlook for 2013, discusses current environment for growth.
  18. Edwards Lowered to Underperform - Analyst Blog

    June 10, 2013
    We downgrade our recommendation on Edwards to Underperform.
  19. Mixed Quarter for Haemonetics - Analyst Blog

    February 1, 2013
    Haemonetics Corporation (HAE) reported net income of $9.9 million or earnings of 19 cents per share in the third quarter ...
  20. Impressive 4Q for Qiagen - Analyst Blog

    January 30, 2013
    Qiagen NV (QGEN) reported earnings per share (EPS) of 16 cents in the fourth quarter of 2012, significantly up from the break-even ...
  21. Cyberonics Approves Share Buyback - Analyst Blog

    January 29, 2013
    In order to uphold investor confidence, neuromodulation company Cyberonics (CYBX) disclosed the approval of a new share repurchase ...
  22. Reiterate Baxter at Neutral - Analyst Blog

    January 29, 2013
    On Jan 28, we retained Baxter International (BAX) at Neutral after the company met Zacks Consensus Estimates for earnings ...
  23. Illumina Posts an Impressive 4Q - Analyst Blog

    January 29, 2013
    Illumina (ILMN) reported fourth quarter 2012 adjusted earnings per share ("EPS") of 42 cents, beating the Zacks Consensus ...
  24. Dismal 4Q for Quest Diagnostics - Analyst Blog

    January 23, 2013
    Leading diagnostic testing company, Quest Diagnostics (DGX) reported earnings per share ("EPS") from continuing operations ...
  25. PetMed Revs in Line, Margins Up - Analyst Blog

    January 23, 2013
    America's largest pet pharmacy, PetMed Express (PETS) reported earnings of 23 cents per share in the third quarter of fiscal ...
  26. Covidien's Device for Hypertension - Analyst Blog

    January 21, 2013
    International health care product major, Covidien plc. (COV) recently revealed the commercialization of its OneShot Renal ...
  27. Medtronic Expands AF Product Line - Analyst Blog

    January 17, 2013
    Leading medical devices player, Medtronic (MDT) has strengthened its growing atrial fibrillation (AF) business. This is on ...
  28. DGX to Sell HemoCue - Analyst Blog

    January 17, 2013
    Following the divestment of its OralDNA Labs salivary-diagnostics business to Access Genetics in Dec 2012, leading diagnostic ...
  29. Haemonetics Upgraded to Outperform - Analyst Blog

    January 11, 2013
    On January 10, we upgraded blood management solutions, Haemonetics Corporation (HAE) to Outperform based on its huge growth ...
  30. Volcano Corporation Stays Neutral - Analyst Blog

    January 11, 2013
    We have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC) based on the company's disappointing third quarter ...
Investing News
  1. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  2. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  3. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  4. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  5. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
  6. Can Paying Off Your Mortgage Early Hurt Your Net Worth?

    Saving your money and making double or even triple payments on a mortgage may sound productive, ...
Trading Center